REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Monday reported a loss of $50.7 million in its fourth quarter.
The Redwood City, California-based company said it had a loss of 44 cents per share. Losses, adjusted for non-recurring costs and stock option expense, came to 28 cents per share.
The drug developer posted revenue of $54.1 million in the period.
For the year, the company reported profit of $28.5 million, or 25 cents per share. Revenue was reported as $267 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
